Navin Pinto
机构: University of Colorado Anschutz Medical Campus
每年引用次数
引用次数
引用: 3,290
H-指数: 24
I10-指数 : 41
出版物: 132
THE SINGLE NUCLEOTIDE POLYMORPHISM RS9908694 IS ASSOCIATED WITH IN VITRO CYCLOPHOSPHAMIDE SENSITIVITY AS WELL AS HIGH-RISK STATUS AND EVENT-FREE SURVIVAL IN PATIENTS WITH NEUROBLASTOMA
Navin Pinto , Eric Gamazon , Anuar Konkashbaev , Nirav Antao
PEDIATRIC BLOOD & CANCER 60 S72 -S72
2013
African ancestry is associated with high-risk disease and event-free survival in children with neuroblastoma
Navin Pinto , Eric R Gamazon , Hae Kyung Im , Anuar Konkashbaev
Cancer Research 72 ( 8_Supplement) 2486 -2486
2012
Germline sequencing improves tumor-only sequencing interpretation in a precision genomic study of patients with pediatric solid tumor
Jaclyn Schienda , Alanna J Church , Laura B Corson , Brennan Decker
JCO Precision Oncology 5 1840 -1852
20
2021
Rationale and design of the targeted agent and profiling utilization registry study
Pam K Mangat , Susan Halabi , Suanna S Bruinooge , Elizabeth Garrett-Mayer
JCO precision oncology 2 1 -14
166
2018
Inability to Achieve a Therapeutic Dose of Tacrolimus in a Pediatric Stem Cell Transplant Patient due to Generic Substitution
Ashraf G Madian , Arun Panigrahi , Minoli A Perera , Navin Pinto
2014
Drug Focus
Navin Pinto , Susan M Ludeman , M Eileen Dolan
Pharmacogenomics 10 ( 12) 1898 -1898
2009
Polyploid circulating stromal cells in blood to identify invasive solid tumors and to prognosticate for highly aggressive cancer subtypes.
Daniel L Adams , Steven H Lin , Harvey I Pass , Martin Joseph Edelman
Journal of Clinical Oncology 42 ( 16_suppl) 3053 -3053
2024
Clinical targeted next-generation panel sequencing reveals MYC amplification is a poor prognostic factor in osteosarcoma
Amanda E Marinoff , Liam F Spurr , Christina Fong , Yvonne Y Li
JCO Precision Oncology 7 e2200334 -e2200334
7
2023
Impact of genomic and clinical factors on outcome of children≥ 18 months of age with stage 3 neuroblastoma with unfavorable histology and without MYCN amplification: a children's oncology group (COG) report
Navin Pinto , Arlene Naranjo , Xiangming Ding , Fan F Zhang
Clinical Cancer Research 29 ( 8) 1546 -1556
6
2023
Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer
Alanna J Church , Laura B Corson , Pei-Chi Kao , Alma Imamovic-Tuco
Nature medicine 28 ( 8) 1581 -1589
23
2022
Leveraging cloud-based computational resources for gene fusion discovery with potential clinical implications for pediatric solid tumor patients
Alma Imamovic , Alanna J Church , Laura B Corson , Deirdre Reidy
CANCER RESEARCH 80 ( 14) 86 -87
2020
Sequencing identifies diagnostically relevant alterations in pediatric solid tumor patients
Alanna J Church , Laura B Corson , Alma Imamovic-Tuco , Gianna R Strand
CANCER RESEARCH 80 ( 14) 74 -75
2020
A high prevalence of chromosomal translocations as drivers in high-risk pediatric solid cancers
Laura B Corson , Alma Imamovic-Tuco , Gianna R Strand , Deirdre Reidy
Cancer Research 79 ( 13_Supplement) 3104 -3104
2019
Intraventricular B7-H3 CAR T cells for diffuse intrinsic pontine glioma: preliminary first-in-human bioactivity and safety
Nicholas A Vitanza , Ashley L Wilson , Wenjun Huang , Kristy Seidel
Cancer discovery 13 ( 1) 114 -131
100
2023
Locoregional CAR T cells for children with CNS tumors: clinical procedure and catheter safety
Nicholas A Vitanza , Rebecca Ronsley , Michelle Choe , Casey Henson
Neoplasia 36 100870 -100870
15
2023
First-in-human comparison of second-versus third-generation L1CAM-specific CAR T cells in patients with primary refractory or relapsed neuroblastoma
Navin Pinto , Annette Künkele , Catherine Albert , Mallory Taylor
2024
Targeted sequencing in 388 patients with high-risk or recurrent/refractory pediatric extracranial solid malignancies: An interim report from the GAIN Consortium/iCat2 Study
Laura B Corson , Alanna J Church , Deirdre Reidy , Pei-Chi Kao
CANCER RESEARCH 80 ( 14) 57 -57
1
2020
iCatalog: An open-source, collaborative platform for precision oncology studies.
Wenjun Kang , Lorena Lazo de la Vega , Hannah Comeau , Laura Corson
Journal of Clinical Oncology 42 ( 16_suppl) 10020 -10020
2024
Evolution of clinically relevant variants in advanced pediatric sarcomas
Hannah Y Comeau , Lorena Lazo De La Vega , Alanna J Church , Luke D Maese
Cancer Research 84 ( 6_Supplement) 2862 -2862
2024
The added value of examining germline variants in a precision cancer therapy study
Jaclyn Schienda , Catherine M Clinton , Laura B Corson , Alma Imamovic-Tuco
CANCER RESEARCH 80 ( 14) 44 -45
2020